ALDR

Alder Biopharmaceuticals, Inc.

ALDR

Delisted

ALDR was delisted on the 21st of October, 2019.

123 hedge funds and large institutions have $1.21B invested in Alder Biopharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 52 increasing their positions, 27 reducing their positions, and 21 closing their positions.

2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2

Holders

123

Holders Change

-1

Holders Change %

-0.81%

% of All Funds

2.67%

Holding in Top 10

Holding in Top 10 Change

Holding in Top 10 Change %

+100%

% of All Funds

0.09%

New

Increased

Reduced

Closed

Calls

$750K

Puts

$373K

Net Calls

+$377K

Net Calls Change

+$797K

Top Buyers

1	1 Wellington Management Group Boston, Massachusetts	$139M
2	PHS 2 PFM Health Sciences San Francisco, California	$31.5M
3	RG 3 Redmile Group San Francisco, California	$113M
4	4 T. Rowe Price Associates Baltimore, Maryland	$124M
5	5 Norges Bank Oslo, Norway	$20M

Top Sellers

1	TCIM 1 TIAA CREF Investment Management New York	$10.2M
2	2 Brown Advisory Baltimore, Maryland	$0
3	3 Point72 Asset Management Stamford, Connecticut	$0
4	4 Citigroup New York	$247K
5	5 Deutsche Bank Frankfurt Am Main Ge, Germany	$265K

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 Wellington Management Group Boston, Massachusetts	$139M	10,159,082	+5,393,959	+113%
2	2 T. Rowe Price Associates Baltimore, Maryland	$124M	9,105,567	+1,393,489	+18%
3	RG 3 Redmile Group San Francisco, California	$113M	8,244,896	+1,739,130	+27%
4	4 Vanguard Group Malvern, Pennsylvania	$89.4M	6,549,249	+1,284,019	+24%
5	5 BlackRock New York	$78.8M	5,774,520	+839,896	+17%
6	6 Goldman Sachs New York	$44.9M	3,289,275	+527,103	+19%
7	SC 7 Samlyn Capital New York	$43.5M	3,185,983	+367,195	+13%
8	8 State Street Boston, Massachusetts	$43.2M	3,165,522	+335,387	+12%
9	9 Citadel Advisors Miami, Florida	$42.3M	3,096,897	+665,922	+27%
10	FCMI 10 Foresite Capital Management III Larkspur, California	$40.2M	2,942,130	–	–
11	BB 11 BB Biotech Schaffhausen, Switzerland	$37.8M	2,766,008	–	–
12	PHS 12 PFM Health Sciences San Francisco, California	$31.5M	2,306,367	+2,306,367	New
13	PAI 13 Palo Alto Investors Palo Alto, California	$25.4M	1,861,630	–	–
14	14 Fidelity Investments Boston, Massachusetts	$24.4M	1,788,219	+168,162	+10%
15	FCMI 15 Foresite Capital Management II Larkspur, California	$21.7M	1,586,220	–	–
16	RSCM 16 Rock Springs Capital Management Baltimore, Maryland	$21.3M	1,560,000	+85,000	+6%
17	17 Norges Bank Oslo, Norway	$20M	1,467,405	+1,350,000	+1,150%
18	BG 18 Bellevue Group Kuesnacht, Switzerland	$17.6M	1,286,748	+162,935	+14%
19	LPC 19 Lion Point Capital New York	$17.4M	1,271,500	+689,470	+118%
20	20 Ameriprise Minneapolis, Minnesota	$17.1M	1,255,790	+115,548	+10%
21	TGHSA 21 TPG Group Holdings (SBS) Advisors Fort Worth, Texas	$16.9M	1,238,533	–	–
22	22 Dimensional Fund Advisors Austin, Texas	$15.9M	1,162,726	+721	+0.1%
23	23 Massachusetts Financial Services Boston, Massachusetts	$12.7M	928,191	+175,389	+23%
24	PA 24 Pinnacle Associates New York	$12.6M	921,104	-5,963	-0.6%
25	25 Geode Capital Management Boston, Massachusetts	$11.9M	868,135	+219,695	+34%

Alder Biopharmaceuticals, Inc. ALDR

Top Buyers

Top Sellers

Alder Biopharmaceuticals, Inc.

ALDR